What is the primary purpose of this debt issuance?

The primary purpose of this debt issuance was to raise capital to repay outstanding debt under CVS Health's bridge loan facility. This suggests a refinancing or restructuring of existing debt obligations.

What are the key terms of the notes issued?

The notes have an aggregate principal amount of $1,000,000,000, bear an interest rate of 6.60%, and mature on March 15, 2019.

How much capital did CVS Health net from this offering?

After deducting underwriting discounts and estimated expenses, CVS Health received net proceeds of approximately $985,815,000 from the offering.

Are there any conflicts of interest with the underwriters involved?

The filing notes that certain underwriters or their affiliates have engaged in past and may engage in future investment and commercial banking transactions with the company. Specifically, some of these entities are lenders under the company's bridge loan facility, and will receive a portion of the net proceeds used to repay that facility. While customary, investors should be aware of these related party transactions.

CVS 8-K SEC Disclosure — Mar 13, 2009

Summary

CVS Health Corporation (then CVS Caremark Corporation) announced on March 12, 2009, the successful completion of a public offering of $1 billion in aggregate principal amount of 6.60% notes due March 15, 2019. The offering, which closed on March 13, 2009, generated net proceeds of approximately $985.8 million after underwriting discounts and estimated expenses. These proceeds are intended to be used, in part, to repay outstanding debt under the Company's bridge loan facility, with certain underwriters or their affiliates acting as lenders under this facility. This debt issuance indicates a strategic move by CVS Health to manage its capital structure and potentially refinance existing obligations. Investors should note the terms of these notes, including the coupon rate and maturity date, as they represent a significant portion of the company's long-term debt. The transaction also highlights the ongoing banking relationships between CVS Health and the underwriters involved in this offering.

Key Highlights

1CVS Health (CVS Caremark Corporation) issued $1 billion in 6.60% notes due March 15, 2019.
2The offering closed on March 13, 2009.
3Net proceeds from the offering are approximately $985.8 million.
4Proceeds are intended for repayment of outstanding debt under the company's bridge loan facility.
5Certain underwriters or their affiliates are lenders under the bridge loan facility.
6The issuance was conducted under the company's existing Registration Statement on Form S-3.

CVS HEALTH Corp 8-K Report, Corporate Update (Mar 13, 2009)

Summary

Key Highlights

Frequently Asked Questions